Navigation Links
Germgard's Ultra-Fast Hand Hygiene Solution Protects Against Deadly MRSA, C difficile, and Influenza Virus
Date:4/29/2009

DOVER, N.J., April 29 /PRNewswire/ -- In an effort to provide technology to reduce healthcare-associated infections, Germgard Lighting LLC, a New Jersey-based early-phase medical device company, has demonstrated its patented ultra-fast (~1 second) hand hygiene solution. The solution is designed to protect hospital patients and medical professionals from exposure to dangerous, life-threatening pathogens in healthcare facilities. It enables effective, frequent and instantaneous hygiene practice at the immediate point of care.

Germgard provides the solution for the philosophy enunciated by The Centers for Disease Control and Prevention, which has produced an infection prevention video to be shown to patients entering the hospital. The goal of the video is to teach patients to demand effective hand hygiene from healthcare workers and doctors, who will take care of them during their stay, as well as visitors so that the patient is not exposed to pathogens leading to an infection.

The message of the video is "Demand that doctors, healthcare workers, and all visitors wash their hands or use alcohol rub each and every time they are about to touch you or your surround," summarizes Germgard CEO Dr. Eugene I. Gordon. He adds, "It warns that hands are contaminated by every surface they touch in the room and inevitably will transfer pathogens to the patient unless the hands are sanitized just before touching the patient."

The Germgard philosophy has been that although the goal is obvious and sound there is no practical way a doctor and healthcare worker can spend 30 seconds or more sanitizing their hands each and every time they must touch the patient. That would add many minutes to the time with each patient and that is prohibitive. Moreover, the skin of the hand would get irritated from so much hand-washing or use of alcohol rubs.

Gordon emphasizes, "The CDC is correct about the cause of hospital acquired infections, but they recommend a solution that is not practicable."

Germgard's unique solution for hand hygiene will resolve the persistent issues of speed, efficacy, and skin irritation that have long plagued hand hygiene practice in hospitals and clinics, and placed at risk millions of patients as well as the financial well-being of healthcare. It will also find applications in schools and food service establishments.

Germgard Lighting LLC is funded by and located in a NJ Commission on Science and Technology supported innovation incubator on the campus of the U.S. Army Picatinny Arsenal. Its technology pipeline enables a multi-tiered approach to infection prevention that includes cost-effective bare and gloved hand sanitation, medical instrument sterilization, surface cleaning, and air sterilization.

    Media Contact:

    Peter Gordon, VP of Marketing, Germgard Lighting LLC
    (Phone) 973-607-1538
    (FAX) 973-607-1543
    (e-mail) pgordon@germgardlighting.com

(Website) http://www.germgardlighting.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Germgard Lighting LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
2. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
3. Haemonetics Announces New Subsidiary, Haemonetics Software Solutions
4. BioLife Solutions Expands Scientific Advisory Board
5. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
6. Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management
7. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
8. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
9. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
10. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
11. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... NY (PRWEB) , ... January 16, 2017 , ... ... New Jersey laws precedential publication its decision on the appeal filed by India-based ... lawsuit of breach of contract against DPCL and one of its Dishman Group’s ...
(Date:1/16/2017)... --  Valentin A. Pavlov, PhD , associate investigator, and ... of The Feinstein Institute for Medical Research ... nervous system regulates the immune system, which will help ... devices to treat disease and injury. The analysis is ... The paper examines various studies which further define the ...
(Date:1/16/2017)... Morrisville, NC (PRWEB) , ... January 16, 2017 ... ... science company, received the prestigious Tibbetts Award from the U.S. Small Business ... participants “that have created a significant economic or social impact […] and are considered ...
(Date:1/16/2017)... , Jan. 16, 2017  Eurofins Genomics today announced ... allow more customers to receive their primers in a ... compromise in quality found with other providers. Express oligos ... States at no additional fee. ... genetic studies, including DNA sequencing, genotyping, site-directed mutagenesis, and ...
Breaking Biology Technology:
(Date:1/13/2017)... 2017 Sandata Technologies, LLC, a leading ... industry, including Electronic Visit Verification™ (EVV™), announced today ... as Senior Vice President of Product Management. ... homecare experience to Sandata, where he will be ... align Sandata,s suite of solutions with the needs ...
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... DNA (ctDNA) technologies, today announced that it has signed ... and the Middle East ...  This milestone marks the first wave of international distribution ... urine and blood samples. The initial partners ...
(Date:1/12/2017)... YORK , Jan. 12, 2017  New research undertaken ... the office of the future.  1,000 participants were simply asked ... three months which we may consider standard issue.  Insights on ... of 2017 were also gathered from futurists and industry leaders ... Dr. James Canton .  Some of ...
Breaking Biology News(10 mins):